PHARMACOKINETICS OF CHLOROQUINE - SALIVA AND PLASMA-LEVELS RELATIONSHIP

[1] ALBERT A, 1981, SELECTIVE TOXICITY P, P330

[2] ARAKI Y, 1951, JAP J PHYSIOL, V2, P255

[3] STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS .6. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (03) : 98 - 107

[4] BERNSTEIN H, 1963, INVEST OPHTH VISUAL, V2, P384

[5] BORZELLECA JF, 1965, J ORAL THER PHARMACO, V2, P180

[6] BINDING OF CHLOROQUINE TO NORMAL AND KWASHIORKOR SERUM [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1977, 26 (05) : 1025 - 1027

[7] DVORCHIK BH, 1976, CLIN CHEM, V22, P868

[8] COMPLETE HEART-BLOCK DUE TO CHRONIC CHLOROQUINE TOXICITY MANAGED WITH PERMANENT PACEMAKER [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6120) : 1109 - 1110

[9] ESSIEN EE, 1984, J TROP MED HYG, V87, P131

[10] ESSIEN EE, 1978, NIGER J PHARM, V9, P53

[1] ALBERT A, 1981, SELECTIVE TOXICITY P, P330

[2] ARAKI Y, 1951, JAP J PHYSIOL, V2, P255

[3] STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS .6. THE PHYSIOLOGICAL DISPOSITION, ANTIMALARIAL ACTIVITY, AND TOXICITY OF SEVERAL DERIVATIVES OF 4-AMINOQUINOLINE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (03) : 98 - 107

[4] BERNSTEIN H, 1963, INVEST OPHTH VISUAL, V2, P384

[5] BORZELLECA JF, 1965, J ORAL THER PHARMACO, V2, P180

[6] BINDING OF CHLOROQUINE TO NORMAL AND KWASHIORKOR SERUM [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1977, 26 (05) : 1025 - 1027

[7] DVORCHIK BH, 1976, CLIN CHEM, V22, P868

[8] COMPLETE HEART-BLOCK DUE TO CHRONIC CHLOROQUINE TOXICITY MANAGED WITH PERMANENT PACEMAKER [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6120) : 1109 - 1110

[9] ESSIEN EE, 1984, J TROP MED HYG, V87, P131

[10] ESSIEN EE, 1978, NIGER J PHARM, V9, P53